Jack Tsai, PhD, MSCP, regional dean and professor of public health at UTHealth and research director for the National Center on Homelessness Among Vet...

At a recent Institute for Value-Based Medicine® event, Oranus Mohammadi, MD, a medical oncologist and hematologist at The Oncology Institute in Los An...

Infections remain one of the leading causes of morbidity and mortality in patients with multiple myeloma (MM), largely due to the profound immunosuppr...

Vaccine skepticism from Republicans continues to gain ground with the decision by Florida Surgeon General Joseph Ladapo, MD, PhD, to end all mandates...

The novel integrase strand transfer inhibitor (INSTI), ACC017, was found to be effective and safe in patients with HIV using the treatment as an antir...

The secretary of HHS, Robert F. Kennedy Jr, was a witness during a hearing of the Senate Committee on Finance aiming to examine the health care agenda...

Publication Article Supplements and Featured Publications This supplement was sponsored by Johnson & Johnson and Legend Biotech. In this AJMC® Roundta...

For individuals living with multiple sclerosis (MS), relapses often leave lasting effects that may contribute to long-term disability. A new systemati...

BeOne Medicines has announced positive topline results in its phase 1/2 study of sonrotoclax, its next-generation BCL2 inhibitor,1 in patients with ma...

Approximately one-fourth of patients with ovarian cancer receive BRCA testing, and those who do are more likely to progress to higher lines of therapy...